[ RECIPIENT ENTITY RECORD ]

Seagen Inc.

VERIFIED NODE ID: 002034 · seagen-inc
R TARGET NODE — CAPITAL RECIPIENT
Seagen Inc.
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Seagen Inc.
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Seagen Inc. is a global biotechnology company that discovers, develops, and commercializes transformative cancer medicines, particularly antibody-drug conjugates. Based in Washington, the firm is a pioneer in targeted oncology therapies. It was the destination for a massive institutional healthcare acquisition by a global pharmaceutical leader.

Capital Influx Log (Transactions)
Date Type Amount
23 May 2026 EQUITY $43.0B